Wipro Consumer Care - Ventures, the venture capital arm of Wipro Consumer Care and Lighting, has invested in Gynoveda which is focused on addressing women’s healthcare issues including gynaecological and lifestyle-related disorders faced by them from puberty to menopause.

“We are excited to form this association with Gynoveda which work on noble causes of how to address the oft-ignored aspects of women’s health. We believe that there are large unaddressed needs of women who suffer and live with these problems where Gynoveda is already making a visible impact with their offerings as well as educational initiatives. The strong team of Vishal, Rachna and Aarti has all the elements to make Gynoveda formidable with the aim of reaching a larger population.” said Sumit Keshan, Managing Partner, Wipro Consumer Care - Ventures. 

“This is aligned with our interests in the health and wellness space, in addition to our existing focus on personal care, fragrances, food, nutrition. This is the tenth investment from our fund” he added.

“Our philosophy is that we can solve gynecological disorders for women, without putting them on life-long medications. We can help them get rid of gynecological problems in a time period of 6-8 months or one year, based on their chronicity,” co-founder and CEO Vishal Gupta said. “Gynoveda has so far improved the health of 3 lakh women residing in 20,000 pin codes of India” he added.

With an aim to revolutionize the USD 9.6 billion global women’s healthcare industry, Gynoveda sells proprietary formulations certified by the United States Food and Drug Administration (FDA) and India’s National Accreditation Board for Testing and Calibration Laboratories. It sells these products via its website as well as ecommerce marketplaces such as Amazon, Flipkart and Nykaa.